Literature DB >> 15464144

A cell biologist's perspective on physiological adaptation to opiate drugs.

Mark von Zastrow1.   

Abstract

Opiate drugs such as morphine and heroin are among the most effective analgesics known but are also highly addictive. The clinical utility of opiates is limited by adaptive changes in the nervous system occurring after prolonged or repeated drug administration. These adaptations are believed to play an important role in the development of physiological tolerance and dependence to opiates, and to contribute to additional changes underlying the complex neurobehavioral syndrome of drug addiction. All of these adaptive changes are initiated by the binding of opiate drugs to a subfamily of G protein-coupled receptors that are also activated by endogenously produced opioid neuropeptides. It is increasingly evident that opiate-induced adaptations occur at multiple levels in the nervous system, beginning with regulation of opioid receptors themselves and extending to a complex network of direct and indirect modifications of "downstream" signaling machinery. Efforts in my laboratory are directed at understanding the biochemical and cell biological basis of opiate adaptations. So far, we have focused primarily on adaptations occurring at the level of opioid receptors themselves. These studies have contributed to defining a set of membrane trafficking mechanisms by which the number and functional activity of opioid receptors are controlled. The role of these mechanisms in affecting adaptation of "downstream" neurobiological substrates, and in mediating opiate-induced changes in whole-animal physiology and behavior, are exciting questions that are only beginning to be explored.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464144     DOI: 10.1016/j.neuropharm.2004.05.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

Review 1.  Look before leaping: combined opioids may not be the rave.

Authors:  Mellar P Davis; Susan B LeGrand; Ruth Lagman
Journal:  Support Care Cancer       Date:  2005-07-06       Impact factor: 3.603

2.  A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.

Authors:  Nikhil M Urs; Tanya L Daigle; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2010-10-27       Impact factor: 7.853

3.  Preventing death among the recently incarcerated: an argument for naloxone prescription before release.

Authors:  Sarah E Wakeman; Sarah E Bowman; Michelle McKenzie; Alexandra Jeronimo; Josiah D Rich
Journal:  J Addict Dis       Date:  2009

4.  Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization.

Authors:  Michael S Virk; John T Williams
Journal:  Mol Pharmacol       Date:  2008-01-15       Impact factor: 4.436

5.  Mu-opioid receptor redistribution in the locus coeruleus upon precipitation of withdrawal in opiate-dependent rats.

Authors:  Jillian L Scavone; Elisabeth J Van Bockstaele
Journal:  Anat Rec (Hoboken)       Date:  2009-03       Impact factor: 2.064

6.  Morphine as a Potential Oxidative Stress-Causing Agent.

Authors:  Jitka Skrabalova; Zdenka Drastichova; Jiri Novotny
Journal:  Mini Rev Org Chem       Date:  2013-11       Impact factor: 2.495

7.  Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling.

Authors:  Elodie Archer-Lahlou; Nicolas Audet; Mohammad Gholi Amraei; Karine Huard; Mélanie Paquin-Gobeil; Graciela Pineyro
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.